Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
< Previous
1
2
3
4
5
6
7
8
Next >
Sigilon Therapeutics Issues An Update On Its Early-Stage Hemophilia Study
November 29, 2021
Tickers
SGTX
Tags
General
SGTX
Phase 2 Trial
From
Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
November 26, 2021
Tickers
SELB
Tags
Benzinga
Biotech
Movers
From
Benzinga
See Why FDA Hit Red Light On Kura's Early-Stage Leukemia Trial
November 24, 2021
Tickers
KURA
Tags
Trading Ideas
Health Care
Phase 1 Trial
From
Benzinga
Aptevo Stock Rallies After Posting First Complete Remission In Early Acute Myeloid Leukemia Trial
November 23, 2021
Tickers
APVO
Tags
Biotech
Movers
Benzinga
From
Benzinga
Affimed's Lymphoma Candidate Shows 100% Objective Response Rate At Highest Dose
November 22, 2021
Tickers
AFMD
Tags
Phase 2 Trial
General
Small Cap
From
Benzinga
Dermata's Aesthetic Improvement Candidate Fails To Impress - Read Why
November 19, 2021
Tickers
DRMA
Tags
General
DRMA
Briefs
From
Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
November 19, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Phase 1 Trial
News
From
Benzinga
Safety Signals Force Enanta To Stop EDP-721 HBV Program
November 19, 2021
Tickers
ENTA
Tags
ENTA
Briefs
Benzinga
From
Benzinga
Plus Therapeutics' Targeted Radiotherapy Shows Encouraging Overall Survival In Brain Tumour Trial
November 18, 2021
Tickers
PSTV
Tags
General
PSTV
brain cancer
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
November 18, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Phase 2 Trial
General
RHHVF
From
Benzinga
Codiak BioSciences' Exosome Candidate Shows Tumor Shrinkage In Early Study
November 16, 2021
Tickers
CDAK
Tags
Market News
Solid Tumor
News
From
Benzinga
Rocket Pharma To Test Lower Dose Of Gene Therapy In Genetic Disorder Trial
November 15, 2021
Tickers
RCKT
Tags
Biotech
Movers
Benzinga
From
Benzinga
Why Are EyePoint Shares Trading Higher Today?
November 15, 2021
Tickers
EYPT
Tags
Market News
why it's moving
Trading Ideas
From
Benzinga
Moderna Posts Interim Data From mRNA Triplet Program In Solid Tumors
November 15, 2021
Tickers
AZN
MRNA
Tags
General
Briefs
Benzinga
From
Benzinga
Why Did Oncorus Shares Slump To 52-Week Low Today?
November 12, 2021
Tickers
ONCR
Tags
why it's moving
Market News
News
From
Benzinga
Agenus Posts Early Data For CTLA-4 Drug Candidate Across Tumor Types
November 12, 2021
Tickers
AGEN
Tags
Solid Tumor
News
Health Care
From
Benzinga
Why Did Mizuho Upgrade This Biotech Stock Focused On Age-Related Eye Diseases?
November 10, 2021
Tickers
UBX
Tags
General
UBX
Age/Related Macular Degeneration
From
Benzinga
Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program
November 10, 2021
Tickers
FRLN
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data
November 10, 2021
Tickers
YMTX
Tags
General
YMTX
Briefs
From
Benzinga
Terns' Potential NASH Candidate Shows Potent Liver Target Engagement
November 10, 2021
Tickers
TERN
Tags
General
Benzinga
Non Alcoholic steatohepatitis
From
Benzinga
Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
November 09, 2021
Tickers
STTK
TAK
TKPHF
Tags
Small Cap
General
Briefs
From
Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
November 09, 2021
Tickers
ALXO
MRK
RHHBF
RHHBY
Tags
Small Cap
General
RHHVF
From
Benzinga
Mirati Posts More Responses For Adagrasib-Keytruda Combo In Lung Cancer Setting
November 09, 2021
Tickers
MRK
MRTX
Tags
Briefs
Non/Small Cell Lung Cancer
Benzinga
From
Benzinga
MorphoSys Presents Early Felzartamab Data From Autoimmune Kidney Disease Trial
November 05, 2021
Tickers
IMAB
MOR
Tags
Market News
Health Care
Phase 1 Trial
From
Benzinga
Why Did Sangamo Stock Jump 20% Today?
November 04, 2021
Tickers
SGMO
Tags
Movers
Biotech
Benzinga
From
Benzinga
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
November 04, 2021
Tickers
MRNA
Tags
News
Trading Ideas
Phase 1 Trial
From
Benzinga
Equillium Reveals Early Safety Data For Itolizumab In Lupus Patients
November 02, 2021
Tickers
EQ
Tags
News
Systemic Lupus Erythematosus
Health Care
From
Benzinga
Cocrystal Pharma Files To Start Human Trial For Protease Inhibitor In COVID-19
November 01, 2021
Tickers
COCP
Tags
Market News
Trading Ideas
Penny Stocks
From
Benzinga
Cabaletta Posts Cell Therapy Data From Third Cohort Of Autoimmune Skin Disorder Trial
November 01, 2021
Tickers
CABA
Tags
Market News
Health Care
Phase 1 Trial
From
Benzinga
Calithera Posts Early-Data For Arginase Inhibitor In Cystic Fibrosis Trial
November 01, 2021
Tickers
CALA
Tags
Market News
Trading Ideas
Penny Stocks
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.